Form 8-K/A - Current report: [Amend]
30 9월 2023 - 5:05AM
Edgar (US Regulatory)
0000885590
true
A1
0000885590
2023-09-18
2023-09-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K/A
(Amendment No. 1)
____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 18, 2023
____________________________
Bausch Health Companies Inc.
(Exact name of registrant as specified in its
charter)
____________________________
British Columbia, Canada |
001-14956 |
98-0448205 |
(State or other jurisdiction
of incorporation or organization) |
(Commission
File Number) |
(I.R.S. Employer
Identification Number) |
2150 St. Elzéar Blvd. West
Laval, Quebec
Canada H7L 4A8
(Address of Principal Executive Offices) (Zip
Code)
514-744-6792
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
____________________________
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section
12(b) of the Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
Common Shares, No Par Value |
BHC |
New York Stock Exchange |
Toronto
Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Explanatory Note
On September 18, 2023, Bausch Health
Companies Inc. (the “Company”) filed a Current Report on Form 8-K under Items 5.02, 7.01 and 9.01 (the “Original Report”)
to report the resignation of Tom G. Vadaketh as Executive Vice President, Chief Financial Officer of the Company, effective October 13,
2023, and the appointment of John S. Barresi, the Company’s Senior Vice President, Controller and Chief Accounting Officer, to
also serve as interim Chief Financial Officer, effective upon Mr. Vadaketh’s termination date. At the time of the filing of the
Original Report, Mr. Barresi’s compensation in connection with his appointment as interim Chief Financial Officer had not been
finalized. The Company is filing this Form 8-K/A as an amendment to the Original Report to disclose the material terms of the changes
made to Mr. Barresi’s compensation in connection with his appointment as interim Chief Financial Officer that were approved by
the Talent and Compensation Committee of the Board of Directors (the “Compensation Committee”) on September 26, 2023.
Item 5.02 Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
In connection with his appointment as
interim Chief Financial Officer, Mr. Barresi will be entitled to receive: (i) a bi-weekly cash stipend of $5,000, which will be paid
in addition to his regular base pay during the time he serves in the role of interim Chief Financial Officer, and (ii) a cash retention
award of $100,000, which will be payable as follows: (i) $50,000 on the first regular payroll date after October 1, 2023, and (ii) $50,000
on the first regular payroll date after October 1, 2024, provided that Mr. Barresi remains an employee on the applicable payment date;
provided that, in the event Mr. Barresi resigns or is terminated for Cause, in either case
within the 12 months following receiving any payment of the cash award, he will be required to reimburse the Company the full amount
of such cash award calculated on an after-tax basis. In addition, while serving as interim Chief Financial Officer, Mr. Barresi will
be eligible for enhanced severance benefits in the event of his termination of employment without “cause” (a “Qualifying
Termination”) equal to 1.5 times the sum of his (i) annual base salary and (ii) target annual cash bonus opportunity, and a pro-rata
annual cash bonus for the year of termination. If Mr. Barresi’s Qualifying Termination occurs during the 12 month period following
a “change of control” while serving as interim Chief Financial Officer, his severance will be equal to two (2) times the
sum of his (i) annual base salary and (ii) target annual cash bonus opportunity and a pro-rata annual cash bonus for the year of termination.
The payment of any such severance is subject to Mr. Barresi’s execution and non-revocation of a release of claims.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits
Exhibit
Number |
|
Description |
104 |
|
The
cover page from this Amended Current Report on Form 8-K/A, formatted in Inline XBRL |
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BAUSCH HEALTH
COMPANIES INC. |
|
|
|
|
|
|
|
By: |
/s/
Seana Carson
|
|
Name: |
Seana
Carson |
|
Title: |
Executive
Vice President, General Counsel |
Date: September 29, 2023
v3.23.3
Cover
|
Sep. 18, 2023 |
Cover [Abstract] |
|
Document Type |
8-K/A
|
Amendment Flag |
true
|
Amendment Description |
On September 18, 2023, Bausch Health
Companies Inc. (the “Company”) filed a Current Report on Form 8-K under Items 5.02, 7.01 and 9.01 (the “Original Report”)
to report the resignation of Tom G. Vadaketh as Executive Vice President, Chief Financial Officer of the Company, effective October 13,
2023, and the appointment of John S. Barresi, the Company’s Senior Vice President, Controller and Chief Accounting Officer, to
also serve as interim Chief Financial Officer, effective upon Mr. Vadaketh’s termination date. At the time of the filing of the
Original Report, Mr. Barresi’s compensation in connection with his appointment as interim Chief Financial Officer had not been
finalized. The Company is filing this Form 8-K/A as an amendment to the Original Report to disclose the material terms of the changes
made to Mr. Barresi’s compensation in connection with his appointment as interim Chief Financial Officer that were approved by
the Talent and Compensation Committee of the Board of Directors (the “Compensation Committee”) on September 26, 2023.
|
Document Period End Date |
Sep. 18, 2023
|
Entity File Number |
001-14956
|
Entity Registrant Name |
Bausch Health Companies Inc.
|
Entity Central Index Key |
0000885590
|
Entity Tax Identification Number |
98-0448205
|
Entity Incorporation, State or Country Code |
A1
|
Entity Address, Address Line One |
2150 St. Elzéar Blvd. West
|
Entity Address, City or Town |
Laval
|
Entity Address, State or Province |
QC
|
Entity Address, Country |
CA
|
Entity Address, Postal Zip Code |
H7L 4A8
|
City Area Code |
514
|
Local Phone Number |
744-6792
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Shares, No Par Value
|
Trading Symbol |
BHC
|
Security Exchange Name |
NYSE
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionDescription of changes contained within amended document.
+ References
+ Details
Name: |
dei_AmendmentDescription |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Bausch Health Companies (NYSE:BHC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 5월(5) 2024
Bausch Health Companies (NYSE:BHC)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024